The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a company led recall for a specific batch of Mydriasert 0.28mg/5.4mg Ophthalmic Insert (Thea Pharmaceuticals) as it is labelled as being for the French market, rather than the UK market.
Further details of the recall, the affected batch, and actions to take are available on the MHRA website.
Want the latest pharmacy news and updates straight to your inbox?
Sign up to our regular newsletter for the latest guidance, news, events and CPD opportunities.
Sign Up
Become an RPS Member today and save up to £26 by choosing annual Direct DebitOR spread the cost by switching to monthly payments.
RPS membership is better value than ever in 2024 - join today!
BECOME A MEMBER TODAY